Request appointment
136 Mountainview BoulevardBasking Ridge, NJ 07920
Overview of Dr. Chalasani
Dr. Sree Bhavani Chalasani is an oncologist in Basking Ridge, NJ and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Overlook Medical Center, and Shore Medical Center. She received her medical degree from Siddhartha Medical College NTR and has been in practice 25 years. She is one of 538 doctors at Memorial Sloan Kettering Cancer Center and one of 56 doctors at Overlook Medical Center who specialize in Oncology. She has more than 10 publications and over 500 citings.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Gastroenterology, 2016 - 2022
Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital CenterFellowship, Hematology and Medical Oncology, 2005 - 2008- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2002 - 2005
Siddhartha Medical College NTRClass of 2001
Certifications & Licensure
CA State Medical License 2011 - Present
FL State Medical License 2022 - Present
NJ State Medical License 2008 - 2027
NY State Medical License 2008 - 2027
PA State Medical License 2022 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2017
Publications & Presentations
PubMed
- 10 citationsAcquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.Celine Yeh, Oliver Artz, Haochen Zhang, Elias-Ramzey Karnoub, Peter Ntiamoah
Clinical Cancer Research. 2026-03-16 - Dual pancreatic carcinomas: clonally related or independent primaries?Joshua D Schoenfeld, Vignesh Ravichandran, Zeynep Tarcan, Hulya Sahin-Ozkan, Allison L Richards
NPJ Precision Oncology. 2026-02-08 - 7 citationsMolecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer.Emily Harrold, Fergus Keane, Henry Walch, Joanne F Chou, Jenna Sinopoli
Clinical Cancer Research. 2024-06-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: